Aprea Therapeutics, Inc. (APRE) — Institutional Holders, Q2 2026
29 institutional investment managers reported a APRE position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.9M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
APRE in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- RENAISSANCE TECHNOLOGIESAdded · +80,700 sh+$64.7K
- CITADEL ADVISORSNew · +58,600 sh+$47.0K
- DIADEMA PARTNERSNew · +44,907 sh+$36.0K
- SUSQUEHANNA INTERNATIONAL GROUP, LLPAdded · +21,921 sh+$17.6K
- NORTHERNNew · +13,705 sh+$11.0K
Biggest sellers
- Scientech ResearchSold out · -60,281 sh-$48.4K
- GEODE CAPITAL MANAGEMENTTrimmed · -44,262 sh-$35.5K
- TWO SIGMA SECURITIESSold out · -13,500 sh-$10.8K
- LPL FinancialTrimmed · -5,000 sh-$4.0K
- UBS Group AGTrimmed · -2,150 sh-$1.7K
APRE 13F holders ranked 1–29 of 29
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | AIGH Capital Management#1 · 1,015,541 sh | 1,015,541 | $814.8K | 0.05% | 0.0% |
| 2 | Vestal Point Capital#2 · 350,000 sh | 350,000 | $280.8K | <0.01% | 0.0% |
| 3 | SPHERA FUNDS MANAGEMENT LTD.#3 · 270,000 sh | 270,000 | $216.6K | 0.03% | 0.0% |
| 4 | Nantahala Capital Management#4 · 205,760 sh | 205,760 | $165.1K | <0.01% | 0.0% |
| 5 | RENAISSANCE TECHNOLOGIES#5 · 105,800 sh | 105,800 | $84.9K | <0.01% | +321.5% |
| 6 | GEODE CAPITAL MANAGEMENT#6 · 74,869 sh | 74,869 | $60.1K | 0.00% | -37.2% |
| 7 | CITADEL ADVISORS#7 · 58,600 sh | 58,600 | $47.0K | 0.00% | New |
| 8 | BNP PARIBAS FINANCIAL MARKETS#8 · 45,211 sh | 45,211 | $36.3K | 0.00% | +13.5% |
| 9 | DIADEMA PARTNERS#9 · 44,907 sh | 44,907 | $36.0K | <0.01% | New |
| 10 | VANGUARD FIDUCIARY#10 · 38,464 sh | 38,464 | $30.8K | 0.00% | 0.0% |
| 11 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#11 · 34,939 sh | 34,939 | $28.0K | 0.00% | +168.4% |
| 12 | MORGAN STANLEY#12 · 25,830 sh | 25,830 | $20.7K | 0.00% | +15.7% |
| 13 | VANGUARD CAPITAL MANAGEMENT#13 · 22,882 sh | 22,882 | $18.4K | 0.00% | +16.6% |
| 14 | LPL Financial#14 · 16,052 sh | 16,052 | $12.9K | 0.00% | -23.8% |
| 15 | HighTower Advisors#15 · 13,864 sh | 13,864 | $11.1K | 0.00% | 0.0% |
| 16 | NORTHERN#16 · 13,705 sh | 13,705 | $11.0K | 0.00% | New |
| 17 | Persistent Asset Partners Ltd#17 · 11,490 sh | 11,490 | $9.2K | <0.01% | New |
| 18 | XTX Topco Ltd#18 · 10,565 sh | 10,565 | $8.5K | <0.01% | New |
| 19 | BlackRock#19 · 7,173 sh | 7,173 | $5.8K | 0.00% | -15.7% |
| 20 | Tower Research Capital (TRC)#20 · 3,590 sh | 3,590 | $2.9K | <0.01% | -30.0% |
| 21 | GROUP ONE TRADING, L.P.#21 · 577 sh | 577 | $463.00 | 0.00% | 0.0% |
| 22 | BARCLAYS PLC#22 · 473 sh | 473 | $379.00 | 0.00% | New |
| 23 | OSAIC#23 · 295 sh | 295 | $236.00 | 0.00% | 0.0% |
| 24 | WealthCollab#24 · 158 sh | 158 | $127.00 | 0.00% | 0.0% |
| 25 | Integrated Wealth Concepts#25 · 46 sh | 46 | $36.00 | 0.00% | New |
| 26 | FMR#26 · 45 sh | 45 | $36.00 | 0.00% | New |
| 27 | SBI Securities , Ltd.#27 · 16 sh | 16 | $13.00 | — | 0.0% |
| 28 | UBS Group AG#28 · 3 sh | 3 | $2.00 | 0.00% | -99.9% |
| 29 | Stonepine Capital Management#29 · 137,174 sh | 137,174 | $0.00 | 0.00% | New |
Funds that sold out of APRE in Q2 2026 (2)
Held APRE at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Scientech Research60,281 sh | 60,281 | $46.0K |
| TWO SIGMA SECURITIES13,500 sh | 13,500 | $10.3K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.